Cargando…
Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
Autores principales: | Ferreira da Silva, Renato, Silva, Ana Marta, Morato, Manuela, Ribeiro‐Vaz, Inês, Polónia, Jorge Junqueira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878095/ https://www.ncbi.nlm.nih.gov/pubmed/36519976 http://dx.doi.org/10.1002/jcph.2195 |
Ejemplares similares
-
Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era
por: Ferreira-da-Silva, Renato, et al.
Publicado: (2021) -
Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey
por: Ferreira-da-Silva, Renato, et al.
Publicado: (2022) -
Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015) -
Adverse reaction signal detection methodology in pharmacoepidemiology
por: Stricker, Bruno H.
Publicado: (2018) -
Minimizing Mistakes and Embracing Uncertainty
Publicado: (2005)